Intrua Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
2,910
-45
-2% -$5.93K 0.03% 351
2026
Q1
$412K Sell
2,955
-931
-24% -$130K 0.04% 302
2025
Q4
$477K Sell
3,886
-14
-0.4% -$1.7K 0.05% 265
2025
Q3
$433K Sell
3,900
-532
-12% -$60.5K 0.05% 280
2025
Q2
$491K Sell
4,432
-4,494
-50% -$478K 0.07% 210
2025
Q1
$1M Sell
8,926
-1,314
-13% -$136K 0.15% 110
2024
Q4
$946K Sell
10,240
-1,219
-11% -$110K 0.15% 114
2024
Q3
$961K Sell
11,459
-902
-7% -$68.8K 0.14% 126
2024
Q2
$848K Buy
12,361
+1,856
+18% +$124K 0.13% 142
2024
Q1
$770K Sell
10,505
-1,556
-13% -$120K 0.11% 171
2023
Q4
$977K Sell
12,061
-83
-0.7% -$6.46K 0.14% 140
2023
Q3
$910K Buy
12,144
+242
+2% +$18.6K 0.15% 130
2023
Q2
$917K Buy
11,902
+1,252
+12% +$99.9K 0.16% 125
2023
Q1
$833K Buy
10,650
+504
+5% +$41.7K 0.17% 122
2022
Q4
$848K Sell
10,146
-8,561
-46% -$678K 0.2% 124
2022
Q3
$1.15M Sell
18,707
-6,705
-26% -$423K 0.31% 74
2022
Q2
$1.57M Buy
25,412
+885
+4% +$54.8K 0.33% 66
2022
Q1
$1.46M Sell
24,527
-1,918
-7% -$123K 0.26% 80
2021
Q4
$1.92M Buy
26,445
+889
+3% +$61.2K 0.34% 60
2021
Q3
$1.71M Buy
25,556
+7,099
+38% +$499K 0.31% 67
2021
Q2
$1.29M Sell
18,457
-275
-1% -$18.4K 0.31% 74
2021
Q1
$1.21M Buy
18,732
+389
+2% +$25.1K 0.31% 72
2020
Q4
$1.07M Sell
18,343
-251
-1% -$15.1K 0.48% 43
2020
Q3
$1.13M Buy
18,594
+8,546
+85% +$593K 0.55% 34
2020
Q2
$685K Buy
+10,048
New +$770K 0.26% 85

Other funds holding GILD

Intrua Financial's GILD Position: Q2 2026 in Review

Intrua Financial reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $5.93K and leaving 2,910 shares worth $368K. The position accounts for 0.03% of the portfolio, ranked #351.

Intrua Financial first reported a position in GILD in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.92M in Q4 2021. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Intrua Financial held 2,910 shares of Gilead Sciences worth $368K as of Q2 2026.
  • Intrua Financial sold 45 Gilead Sciences shares in Q2 2026, an estimated $5.93K.
  • Gilead Sciences made up 0.03% of Intrua Financial's portfolio in Q2 2026, its #351 holding.
  • Intrua Financial first reported a position in Gilead Sciences in Q2 2020 and has held it in 25 quarters since.
  • Intrua Financial's Gilead Sciences position peaked at $1.92M in Q4 2021.
  • 836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Intrua Financial's 13F filing for Q2 2026, filed 24 Jul 2026.